Business Development and Commercialization of UroSense™.

Future Path Medical Holding Company, LLC is a medical device start-up company that has developed a breakthrough product called UroSense™. The device is a sensor-integrated urine drainage bottle that automates urine output and core body temperature (CBT) data in catheterized patients. These two vital signs are currently being measured by manual, time-intensive and inaccurate methods and are important indicators to facilitate early treatment and diagnosis. UroSense™ is an advanced urological system that is also equipped with programmable alarms that trigger when the urine bottle is full thus serving as a warning system to caregivers. Future Path Medical has targeted the hospital intensive care unit (ICU) market as its early adopters focusing on catheterized patients. The company has secured two patents for its device and has received class II 510K approval from the FDA. Future Path Medical is currently in its pre-production stage of the device and intends to launch the product in the market in 2013.

Name thesis:degree_name

Master of Sciences

Level thesis:degree_level

masters

Discipline thesis:degree_discipline

Biology

Grantor dc:publisher

Case Western Reserve University School of Graduate Studies

Year dc:date

2013

Author dc:creator

• Pasha, Malaikah

Contributors dc:contributor

• Ritzmann, Roy

• Biology
• Business Education

Statement dc:rights

• unrestricted
• This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.

Language dc:language

English

Repository record dc:identifier

http://rave.ohiolink.edu/etdc/view?acc_num=case1365441184

OAI identifier oai:identifier

oai:etd.ohiolink.edu:case1365441184